(Q41925418)

14 October 2017

High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours (English)

1 reference

14 October 2017

Barnett MJ

1

1 reference

14 October 2017

Coppin CM

2

1 reference

14 October 2017

Murray N

3

1 reference

14 October 2017

Nevill TJ

4

1 reference

14 October 2017

Reece DE

5

1 reference

14 October 2017

Klingemann HG

6

1 reference

14 October 2017

Shepherd JD

7

1 reference

14 October 2017

Nantel SH

8

1 reference

14 October 2017

Sutherland HJ

9

1 reference

14 October 2017

Phillips GL

10

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

British Journal of Cancer

14 October 2017

1 reference

14 October 2017

68

1 reference

14 October 2017

3

1 reference

14 October 2017

594-598

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1993.392

14 October 2017

0 references

cites work

High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Autologous bone marrow transplantation. Current status and future directions

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Prognostic factors for favorable outcome in disseminated germ cell tumors

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

High-dose ifosfamide with mesna uroprotection: a phase I study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin's disease

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Treatment of testicular cancer: a new and improved model

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968411

High-dose chemotherapy supported with autologous bone marrow transplantation (ABMT) in germ cell tumors: a phase two study

18 August 2018

1 reference

12 December 2020

Autologous marrow transplantation in cancer therapy

1 reference

12 December 2020

Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function

1 reference

12 December 2020

1 reference

12 December 2020

The impact of breakthrough clinical trials on survival in population based tumor registries

1 reference

12 December 2020

High dose carboplatin/VP-16 plus ifosfamide with autologous bone marrow support in the treatment of refractory germ cell tumors

1 reference

12 December 2020

Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors

1 reference

12 December 2020

Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer

1 reference

12 December 2020

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

1 reference

12 December 2020

The treatment of advanced testicular carcinoma with high dose chemotherapy and autologous marrow support

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.392

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

8394733

1 reference